Growing community of inventors

Saint-Bruno-de-Montarville, Canada

Michael Dore

Average Co-Inventor Count = 6.13

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Michael DorePierre Louis Beaulieu (45 patents)Michael DorePierre Louis Beaulieu (3 patents)Michael DoreMartin Sendzik (2 patents)Michael DoreZhuoliang Chen (2 patents)Michael DoreMatthew J LaMarche (2 patents)Michael DoreLawrence Blas Perez (2 patents)Michael DoreTroy Douglas Smith (2 patents)Michael DoreRajesh Karki (2 patents)Michael DoreJorge Garcia Fortanet (2 patents)Michael DoreMitsunori Kato (2 patents)Michael DoreChristine Hiu-Tung Chen (2 patents)Michael DoreBakary-Barry Toure (2 patents)Michael DoreSarah Williams (2 patents)Michael DoreJohn William Giraldes (2 patents)Michael DoreJoanne Tan (2 patents)Michael DoreMukund Ghavre (2 patents)Michael DoreYannick Rose (2 patents)Michael DoreEric Beaulieu (2 patents)Michael DoreDoris Schuetz (2 patents)Michael DoreLing Li (1 patent)Michael DoreJacques Banville (1 patent)Michael DoreJulien Papillon (1 patent)Michael DoreYuan Mi (1 patent)Michael DoreZhengtian Yu (1 patent)Michael DoreSasmita Tripathy (1 patent)Michael DoreYannick Rose (8 patents)Michael DoreXiang-Ju Justin Gu (1 patent)Michael DoreJi Yue (Jeff) Zhang (1 patent)Michael DoreXiaoxia Yan (1 patent)Michael DoreCounde Oyang (1 patent)Michael DoreXuan Dai (1 patent)Michael DoreKehao Zhao (1 patent)Michael DoreHugo Lavoie (1 patent)Michael DoreKun Chin Liu (1 patent)Michael DoreWei (Vicky) Qi (1 patent)Michael DoreEmeline Benoit (1 patent)Michael DoreSing Yeung Frankie Mak (1 patent)Michael DoreHugo Lavoie (0 patent)Michael DoreJoanne Tan (0 patent)Michael DoreMichael Dore (6 patents)Pierre Louis BeaulieuPierre Louis Beaulieu (45 patents)Pierre Louis BeaulieuPierre Louis Beaulieu (3 patents)Martin SendzikMartin Sendzik (38 patents)Zhuoliang ChenZhuoliang Chen (32 patents)Matthew J LaMarcheMatthew J LaMarche (30 patents)Lawrence Blas PerezLawrence Blas Perez (23 patents)Troy Douglas SmithTroy Douglas Smith (22 patents)Rajesh KarkiRajesh Karki (16 patents)Jorge Garcia FortanetJorge Garcia Fortanet (16 patents)Mitsunori KatoMitsunori Kato (16 patents)Christine Hiu-Tung ChenChristine Hiu-Tung Chen (16 patents)Bakary-Barry ToureBakary-Barry Toure (15 patents)Sarah WilliamsSarah Williams (13 patents)John William GiraldesJohn William Giraldes (8 patents)Joanne TanJoanne Tan (4 patents)Mukund GhavreMukund Ghavre (2 patents)Yannick RoseYannick Rose (2 patents)Eric BeaulieuEric Beaulieu (2 patents)Doris SchuetzDoris Schuetz (2 patents)Ling LiLing Li (39 patents)Jacques BanvilleJacques Banville (27 patents)Julien PapillonJulien Papillon (25 patents)Yuan MiYuan Mi (21 patents)Zhengtian YuZhengtian Yu (10 patents)Sasmita TripathySasmita Tripathy (9 patents)Yannick RoseYannick Rose (8 patents)Xiang-Ju Justin GuXiang-Ju Justin Gu (7 patents)Ji Yue (Jeff) ZhangJi Yue (Jeff) Zhang (6 patents)Xiaoxia YanXiaoxia Yan (3 patents)Counde OyangCounde Oyang (3 patents)Xuan DaiXuan Dai (2 patents)Kehao ZhaoKehao Zhao (2 patents)Hugo LavoieHugo Lavoie (2 patents)Kun Chin LiuKun Chin Liu (2 patents)Wei (Vicky) QiWei (Vicky) Qi (1 patent)Emeline BenoitEmeline Benoit (1 patent)Sing Yeung Frankie MakSing Yeung Frankie Mak (1 patent)Hugo LavoieHugo Lavoie (0 patent)Joanne TanJoanne Tan (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (3 from 3,923 patents)

2. Universitéde Montreal (3 from 183 patents)


6 patents:

1. 12479842 - Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease

2. 12473273 - Quinoline compounds and compositions for inhibiting EZH2

3. 12209098 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

4. 12139488 - Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease

5. 12060353 - Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease

6. 11952386 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…